TY - JOUR
AU - Fraser, Douglas
AB - INTRODUCTIONTranscatheter aortic valve implantation (TAVI) is a safe and effective treatment for severe symptomatic aortic stenosis in patients deemed high risk for conventional aortic valve surgery. In contrast to conventional valve surgery, which may include coronary artery bypass graft (CABG) surgery, there may be no simple interventional solution for the treatment of concomitant coronary artery disease with TAVI, which has been reported to be present in 60% of patients requiring aortic valve intervention . Percutaneous coronary intervention (PCI) of coronary lesions subtending a large territory has been recommended prior to TAVI for symptomatic benefit and to optimize TAVI outcomes .Whilst the bleeding risk associated with transfemoral TAVI and dual antiplatelet therapy (DAPT) may be accepted, bleeding complications associated with DAPT are of concern, particularly if transapical or transaortic TAVI are performed shortly after implantation of drug‐eluting stents. Consequently, patients with complex coronary disease and severe aortic stenosis requiring urgent TAVI may be difficult to treat if the femoral access is unsuitable for vascular access. Furthermore, patients with concomitant complex coronary anatomy unsuitable for PCI may have few treatment options except high‐risk conventional cardiac surgery. As a potential solution to treat such patients, we describe a hybrid technique of transaortic 
TI - Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series
JF - Catheterization and Cardiovascular Interventions
DO - 10.1002/ccd.26610
DA - 2017-06-01
UR - https://www.deepdyve.com/lp/wiley/feasibility-of-hybrid-off-pump-artery-bypass-grafting-and-transaortic-sv50PS5EqF
SP - 1273
EP - 1279
VL - 89
IS - 7
DP - DeepDyve
ER -